Living Biobank Of Brain Metastasis Samples Enabling ‘Personalized Medicine 2.0’

Clinical Research News | Researchers at the CNIO (Spanish National Cancer Research Centre) are forwarding the idea that metastasis, rather than the primary tumor, should be the focus of cancer treatment, which would both further the cause of personalized medicine and generate biomarkers of sensitivity or resistance to specific drugs.